Blue Owl OWL Stock Up 196 Key Resistance at 1012 20260518 Osprey OBTC Falls 301 Watching 2346 Support 20260518 Why Weibo WB Just Dropped 350 What to Watch 20260514 Caledonia CMCL Stock Slides 403 Support at 2180 20260515 Inotiv NOTV Q1 2026 Stumbles EPS 094 Misses Target China Chides US After Trump Says He Will Talk to Taiwans Lai FirstCash Holdings FCFS Crushes Q1 2026 Estimates EPS 269 Tops Views UFC CEO Dana White Urges Trump to Reverse Gambling Tax Law Prediction Market Reacts Taiwan Chip Stocks Rally After Nvidias 150 Billion Spending Commitment Mainland China Peers Decline Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office 82 Million Weekend RBI Approves Sandeep Bakhshis Reappointment as ICICI Bank CEO for Two More Years AI Economy Reshapes Labor Market BlueCollar Workers Could Emerge as Key Beneficiaries Walmart Eyes Price Cuts Funded by Tariff Refunds as Consumer Caution Grows Barclays Reports 18 Profit Increase Raises Income Guidance Amid Strong Performance Educational Development Corporation Q1 2026 Earnings Reported Loss of 037 Per Share Stock Declines White Mountains Insurance Group Ltd WTM Q2 2025 Earnings EPS Misses Estimates Stock Edges Higher BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains BCAL Q1 2026 Earnings EPS Surprise of 276 Highlights Solid Performance Despite Minor Stock Decline ONB Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Edges Higher Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CBNA Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback Weyco Group Inc WEYS Q1 2026 Earnings Solid EPS Performance Amidst Quiet Quarter Celanese Corporation Q1 2026 Earnings EPS Miss Amid Cost Headwinds Stock Edges Lower CNB Financial Corporation Q1 2026 Earnings EPS Beats Estimates by 74 as Stock Declines BY Q1 2026 Earnings EPS Beats Estimates by 755 Stock Slightly Down Yahoo Finances Weekly Stock List What Investors Should Know BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline